CGNSF Cognetivity Neurosciences Ltd.

Cognetivity Neurosciences Ltd. is a technology company, which engages in the development of platforms for medical uses such as early detection and monitoring of cognitive impairment in neurodegenerative diseases. It uses visual stimulus based diagnostic test and artificial intelligence tools, such as Integrated Cognitive Assessment. The company was founded by Dr. Sina Habibi and Dr. Seyed-Mahdi Khaligh-Razavi on December 11, 2015 and is headquartered in Vancouver, Canada.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$0.39    OTCQB
As of 01/26/2022     OTCMarkets

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Unknown
Industry:  Diagnostics & Research
Index country:  Canada
Country of incorporation:  
IPO date:  10/04/2018
Outstanding shares:  76,498,771
Average volume:  18,287
Market cap:   $29,643,274
Current dividend yield:  0.00%
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   129.17
PS ratio:   0.00
Return on equity:   297.22%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy